Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/11/2025

Treatment of Herpes Flareups

Episodic Treatment for Recurrent Episodes

  • The Centers for Disease Control and Prevention recommends valacyclovir 500 mg orally twice daily for 3 days as the first-line treatment for recurrent genital herpes episodes, initiated at the first sign of prodrome or lesion onset 1
  • Treatment must be initiated during prodrome or within 1 day of lesion onset for maximum benefit, with efficacy dropping significantly if treatment is delayed beyond 24 hours of symptom onset 1, 2
  • Alternative regimens include acyclovir 400 mg orally three times daily for 5 days, acyclovir 800 mg orally twice daily for 5 days, acyclovir 200 mg orally five times daily for 5 days, and famciclovir 125 mg orally twice daily for 5 days 1

Suppressive Therapy for Frequent Recurrences

  • The American College of Obstetricians and Gynecologists recommends daily suppressive therapy for patients with ≥6 recurrences per year, with valacyclovir 1 gram orally once daily as the standard dose 1
  • Suppressive therapy reduces recurrence frequency by ≥75%, with valacyclovir 500 mg orally once daily as an alternative for patients with <10 recurrences per year 1, 2

Special Populations and Considerations

  • For HIV-infected patients with CD4+ count ≥100 cells/mm³, the CDC recommends valacyclovir 500 mg twice daily for suppressive therapy, with more aggressive therapy potentially required compared to immunocompetent individuals 3, 4
  • The National Institutes of Health recommends dosage adjustment for patients with reduced renal function, with valacyclovir used with caution in patients with impaired renal clearance 5

Critical Pitfalls to Avoid

  • The CDC advises against using topical acyclovir due to its substantially lower effectiveness compared to oral therapy, with topical formulations providing minimal clinical benefit compared to systemic treatment 1, 2, 3
  • Patients should be counseled that antiviral medications control symptoms but do not eradicate latent virus or prevent all future recurrences, with asymptomatic viral shedding potentially leading to transmission even without visible lesions 1, 2

Herpes Labialis (Cold Sores)

  • For herpes labialis, the American Academy of Dermatology recommends valacyclovir 2 grams orally twice daily for 1 day, taken 12 hours apart, initiated at the earliest symptom 2

REFERENCES

1

Treatment for Recurrent Genital Herpes [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Valacyclovir for Recurrent HSV-1 Labial Episode [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Valacyclovir Dosing for Herpes Zoster [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025